These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21077296)

  • 1. [Treating drug dependent patients through outpatient group therapy-Serigaya Methamphetamine Relapse Prevention Program (SMARPP)].
    Kobayashi O
    Seishin Shinkeigaku Zasshi; 2010; 112(9):877-84. PubMed ID: 21077296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A preliminary study on outpatient relapse prevention program for methamphetamine dependent patients: Serigaya Methamphetamine Relapse Prevention Program (SMARPP)].
    Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Harai H; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2007 Oct; 42(5):507-21. PubMed ID: 18051470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the Japanese mental health service lacking for drug dependence rehabilitation?].
    Matsumoto T; Kobayashi O
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):172-87. PubMed ID: 18646643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Response to treatment of patients abusing the "dappou drug" who participated in a group relapse prevention program: a comparison with patients abusing methamphetamine].
    Hikitsuchi E; Matsumoto T; Wada K; Tanibuchi Y; Takano A; Imamura F; Kawachi H; Wakabayashi A; Kato T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Dec; 49(6):318-29. PubMed ID: 25831947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the Serigaya Methamphetamine Relapse Prevention Program (SMARPP): for patients with drug use disorder: A study on factors influencing 1-year follow-up outcomes].
    Tanibuchi Y; Matsumoto T; Imamura F; Wakabayashi A; Kawachi H; Hikitsuchi E; Takano A; Yonezawa M; Kato T; Yamada M; Wachi A; Aboshi M; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Feb; 51(1):38-54. PubMed ID: 27295823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness evaluation of Serigaya Methamphetamine Relapse Prevention Program in drug addiction rehabilitation center.
    Kondo A; Kuritsubo C; Shirakawa Y; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Dec; 51(6):414-424. PubMed ID: 30461249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development and evaluation of a relapse prevention tool for drug-abusing delinquents incarcerated in a juvenile classification home: a self-teaching workbook for adolescents, the "SMARPP-Jr].
    Matsumoto T; Imamura F; Kobayashi O; Chiba Y; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Jun; 44(3):121-38. PubMed ID: 19618838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Treatment for Drug Dependence not Requiring Specialists: A Treatment Program based on a Workbook, the "SMARPP"].
    Matsumoto T
    Seishin Shinkeigaku Zasshi; 2015; 117(8):655-62. PubMed ID: 26642733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan.
    Takano A; Miyamoto Y; Kawakami N; Matsumoto T; Shinozaki T; Sugimoto T
    BMC Psychiatry; 2016 Apr; 16():87. PubMed ID: 27044304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigating actual conditions to clarify issues accompanying SMARPP].
    Kondo C; Takano A; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2015 Apr; 50(2):66-87. PubMed ID: 26255432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey.
    Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Wada K; Hirayasu Y
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):526-32. PubMed ID: 18950371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvement in the therapeutic attitudes of health care professionals who offer cognitive behavioral therapy towards substance abusers].
    Takano A; Kawakami N; Miyamoto Y; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Feb; 49(1):28-38. PubMed ID: 24818356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug preferences in illicit drug abusers with a childhood tendency of attention deficit/hyperactivity disorder: a study using the Wender Utah Rating Scale in a Japanese prison.
    Matsumoto T; Yamaguchi A; Asami T; Kamijo A; Iseki E; Hirayasu Y; Wada K
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):311-8. PubMed ID: 15896225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social and legal factors related to drug abuse in the United States and Japan.
    Greberman SB; Wada K
    Public Health Rep; 1994; 109(6):731-7. PubMed ID: 7800780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible effectiveness of intervention using a self-teaching workbook in adolescent drug abusers detained in a juvenile classification home.
    Matsumoto T; Chiba Y; Imamura F; Kobayashi O; Wada K
    Psychiatry Clin Neurosci; 2011 Oct; 65(6):576-83. PubMed ID: 22003990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of effective treatment for alcohol and drug disorders.
    Hoffmann NG; Miller NS
    Psychiatr Clin North Am; 1993 Mar; 16(1):127-40. PubMed ID: 8456039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illegal drug-attributable morbidity in Canada 2002.
    Popova S; Rehm J; Patra J; Baliunas D; Taylor B
    Drug Alcohol Rev; 2007 May; 26(3):251-63. PubMed ID: 17454014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
    McKay JR; Lynch KG; Shepard DS; Pettinati HM
    Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.